Article
Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
11 Apr 2017
Abstract excerpt
-mutant cancer cells is being targeted with platinum drugs and poly (ADP-ribose) polymerase (PARP) inhibitors. We have employed relatively simple and sensitive assays to determine the function of BRCA1 variants or mutants in two HDR mechanisms, homologous recombination (HR) and single strand annealing (SSA), and in conferring resistance to cisplatin and olaparib in human cancer cells. Our results define the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
